ALMS 10-Q: SEC filing

Alumis Inc.

Filed with the SEC on · accession 0001847367-26-000024

ALMS filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -7.4% by the first close after the filing.

Summary of the filing

Alumis Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting collaboration revenue from its Kaken Pharmaceutical arrangement and ongoing clinical-stage operations.

Key details

Collaboration partner for esk-001Kaken Pharmaceutical Co., Ltd.
Acquisition-related severance referenceAcelyrin, Inc.

How ALMS stock reacted

Close before

$6.62

Nov 11, 2026

First close after

-7.40%

$6.13

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ALMS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ALMS?

Click here

Frequently asked questions

What did ALMS file with the SEC on Nov 12, 2026?

ALMS filed a 10-Q (SEC filing). Alumis Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting collaboration revenue from its Kaken Pharmaceutical arrangement and ongoing clinical-stage operations.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ALMS stock react to this filing?

ALMS closed at $6.62 before the filing and $6.13 on Nov 12, 2026 (-7.40%).

Other ALMS SEC filings

Get alerts when ALMS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days